OPKO Health, Inc.

NasdaqGS:OPK 株式レポート

時価総額:US$871.2m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

OPKO Health マネジメント

マネジメント 基準チェック /34

OPKO Health'sの CEO はPhil Frostで、 Mar2007年に任命され、 の在任期間は 17.25年です。 の年間総報酬は$ 2.28Mで、 42.2%給与と57.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の35.07%を直接所有しており、その価値は$ 305.54M 。経営陣と取締役会の平均在任期間はそれぞれ9.3年と15.2年です。

主要情報

Phil Frost

最高経営責任者

US$2.3m

報酬総額

CEO給与比率42.2%
CEO在任期間17.3yrs
CEOの所有権35.1%
経営陣の平均在職期間9.3yrs
取締役会の平均在任期間15.2yrs

経営陣の近況

Recent updates

OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Dec 30
OPKO Health, Inc. (NASDAQ:OPK) Not Flying Under The Radar

Is OPKO Health (NASDAQ:OPK) A Risky Investment?

Oct 03
Is OPKO Health (NASDAQ:OPK) A Risky Investment?

OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Jul 24
OPKO Health, Inc.'s (NASDAQ:OPK) 28% Share Price Surge Not Quite Adding Up

Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Jun 07
Would OPKO Health (NASDAQ:OPK) Be Better Off With Less Debt?

Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

Jan 04
Is OPKO Health (NASDAQ:OPK) Using Too Much Debt?

OPKO Health: Assessing If Significant Potential Can Be Realized

Sep 15

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Sep 05
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: 14%+ Short Interest Means More Volatility Over The Near Term

Jun 21

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

Apr 29
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt

OPKO Health: A Great Long-Term Investment In Health

Apr 05

OPKO Health Is Risky But Might Make You Money

Mar 29

Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

Feb 27
Analysts Have Just Cut Their OPKO Health, Inc. (NASDAQ:OPK) Revenue Estimates By 14%

OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

Jan 12
OPKO Health (NASDAQ:OPK) Has A Pretty Healthy Balance Sheet

OPKO Health: Undervalued Opportunity

Dec 23

OPKO Health: Bullish Case Still Intact

Dec 15

We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

Sep 27
We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt

OPKO Health: A Defensive, Long-Term Holding

Sep 19

CEO報酬分析

OPKO Health の収益と比較して、Phil Frost の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$252m

Dec 31 2023US$2mUS$960k

-US$189m

Sep 30 2023n/an/a

-US$208m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$291m

Dec 31 2022US$972kUS$960k

-US$328m

Sep 30 2022n/an/a

-US$317m

Jun 30 2022n/an/a

-US$202m

Mar 31 2022n/an/a

-US$117m

Dec 31 2021US$2mUS$960k

-US$30m

Sep 30 2021n/an/a

US$76m

Jun 30 2021n/an/a

US$71m

Mar 31 2021n/an/a

US$121m

Dec 31 2020US$2mUS$960k

US$31m

Sep 30 2020n/an/a

-US$114m

Jun 30 2020n/an/a

-US$200m

Mar 31 2020n/an/a

-US$293m

Dec 31 2019US$1mUS$960k

-US$315m

Sep 30 2019n/an/a

-US$279m

Jun 30 2019n/an/a

-US$244m

Mar 31 2019n/an/a

-US$191m

Dec 31 2018US$2mUS$960k

-US$153m

Sep 30 2018n/an/a

-US$295m

Jun 30 2018n/an/a

-US$303m

Mar 31 2018n/an/a

-US$314m

Dec 31 2017US$971kUS$960k

-US$305m

報酬と市場: Philの 総報酬 ($USD 2.28M ) は、 US市場 ($USD 3.40M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Philの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Phil Frost (88 yo)

17.3yrs

在職期間

US$2,277,200

報酬

Dr. Phillip Frost, also known as Phil, M.D., Ph D., is Director of Non-Invasive Monitoring Systems, Inc. since June 01, 2023. He has been the Chairman, Chief Executive Officer and Director of OPKO Health,...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Phillip Frost
Chairman & CEO17.3yrsUS$2.28m35.07%
$ 305.5m
Jane Hsiao
Vice Chairman & Chief Technical Officer17.3yrsUS$2.19m4.75%
$ 41.4m
Elias Zerhouni
President & Vice Chairman2.1yrsUS$2.19m2.93%
$ 25.5m
Adam Logal
Senior VP17.3yrsUS$1.81m0.026%
$ 224.0k
Steven Rubin
Executive VP of Administration & Director17.1yrsUS$1.94m0.89%
$ 7.7m
Akhtar Ashfaq
Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal7.3yrsデータなしデータなし
Gary Nabel
Chief Innovation Officer & Director2.1yrsデータなし5.75%
$ 50.1m
Charles Bishop
Chief Executive Officer of OPKO Renal11.3yrsデータなしデータなし
Antonio Cruz
President of Transition Therapeuticsno dataデータなしデータなし
Hans Berner
President of OPKO Health Iberoamericano dataデータなしデータなし
Damien Burke
Chief Executive Officer of EirGen Pharma4.6yrsデータなしデータなし
Craig Allen
Interim CEO1.8yrsデータなしデータなし

9.3yrs

平均在職期間

71.5yo

平均年齢

経験豊富な経営陣: OPKの経営陣は経験豊富で経験豊富です(平均在職期間は9.3年)。


取締役

名称ポジション在職期間報酬所有権
Phillip Frost
Chairman & CEO17.3yrsUS$2.28m35.07%
$ 305.5m
Jane Hsiao
Vice Chairman & Chief Technical Officer17.3yrsUS$2.19m4.75%
$ 41.4m
Elias Zerhouni
President & Vice Chairman2.1yrsUS$2.19m2.93%
$ 25.5m
Steven Rubin
Executive VP of Administration & Director17.3yrsUS$1.94m0.89%
$ 7.7m
Gary Nabel
Chief Innovation Officer & Director2.1yrsデータなし5.75%
$ 50.1m
Roger Medel
Independent Director3.5yrsUS$69.90k0%
$ 0
Richard Pfenniger
Lead Independent Director16.4yrsUS$134.80k0.047%
$ 406.3k
Richard Krasno
Independent Director7.3yrsUS$92.40k0.015%
$ 129.2k
John Paganelli
Independent Director20.5yrsUS$84.90k0.056%
$ 491.9k
Prem Lachman
Independent Director3.3yrsUS$92.40k0%
$ 0
Lin-Tsing Yu
Independent Director15.2yrsUS$62.40k0.0095%
$ 83.1k

15.2yrs

平均在職期間

77yo

平均年齢

経験豊富なボード: OPKの 取締役会 は経験豊富で 経験豊富 です ( 15.2年の平均在任期間)。